Invasive Disease

Over a period of 3 weeks, just after the end-of-the-year holidays, three healthy siblings presented with swollen lymph nodes.

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with HER2-positive breast cancer, according to long-term results of a randomized phase 3 trial.

CHICAGO — Aspirin was not linked to a benefit in invasive disease-free survival, according to updated study results presented at ASCO Annual Meeting.